Effects of chronic acetazolamide administration on fluid flux from the pulmonary vasculature at rest and during exercise in horses.

The research article investigates the effect of chronic acetazolamide administration on fluid transfer from pulmonary blood vessels during rest and exercise in horses. The study found that long-term acetazolamide treatment with associated high carbon dioxide levels and acidosis affects fluid flow in the lungs of exercising horses.

Research Objectives

The purpose of the research was to determine how fluid moved across the lungs (fluid flux) in horses who were regularly treated with acetazolamide, a medication used to treat conditions in horses such as glaucoma and altitude sickness.

• The research team wanted to ascertain how this medication can affect fluid dynamics in the lungs while the horses were resting and when they were exercising.
• The expectation was that the medication would significantly alter the fluid flux capacity of the lungs, especially during the physical strain of exercise.

Research Methodology

The methodology used for the research involved exercising six horses on a treadmill after treating some with acetazolamide (AczTr) and leaving some untreated as a control group (Con).

• Chronic carbonic anhydrase inhibition was achieved through the administration of acetazolamide.
• During the exercise, the team collected arterial and mixed venous blood samples to measure VCO2 and VO2, indicators of metabolism and oxygen use in the body.
• Changes in blood volume across the lung were then analyzed, computed using changes in plasma protein, haemoglobin, and packed cell volume.
• Finally, cardiac output was calculated, and the flux across the alveolar-capillary barrier was quantified based on cardiac output and changes in blood volume.

Research Findings

The research findings indicated a significant effect of acetazolamide treatment on fluid flux from blood vessels in the lungs.

• There was no fluid transfer in the control group or the treated group when at rest.
• Fluid moved from pulmonary blood vessels into the surrounding lung tissue in the control group during exercise.
• This phenomenon was not observed in the acetazolamide-treated group during exercise.
• The absence of fluid transfer from the pulmonary circulation in the treated horses is a novel finding of this study.

Conclusions

The research concluded that long-term acetazolamide treatment, alongside associated high carbon dioxide levels and increased acidity, impacts fluid transfer in the lungs of exercising horses. This implies that lung fluid dynamics respond to changes in CO2 and acidity levels by reducing fluid flow from pulmonary blood vessels, which could potentially affect oxygenation and performance in exercising horses. This finding is of significant value in understanding lung physiology and pathology in horses during exercise.